Versavo 400mg Bevacizumab Injection

Versavo 400mg Bevacizumab Injection is a targeted anti-cancer medication containing Bevacizumab, a monoclonal antibody used to treat several types of cancer, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It works by blocking vascular endothelial growth factor (VEGF), a protein that helps tumors develop new blood vessels required for growth and spread. By reducing the blood supply to cancer cells, Versavo 400mg Bevacizumab Injection helps slow tumor progression and supports effective cancer management. Administered as an intravenous infusion under the supervision of a qualified healthcare professional, it is often used in combination with chemotherapy or other cancer treatments. Regular medical monitoring is important during therapy to assess treatment response and manage potential side effects. Patients should follow their oncologist’s guidance to ensure the safe and effective use of Versavo 400mg Injection.